HEADER VIRAL PROTEIN 10-SEP-13 4C53 TITLE CRYSTAL STRUCTURE OF GUANARITO VIRUS GP2 IN THE POST-FUSION TITLE 2 CONFORMATION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PRE-GLYCOPROTEIN POLYPROTEIN GP COMPLEX; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: ECTODOMAIN, RESIDUES 292-418; COMPND 5 SYNONYM: GTOV GP2; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: N-LINKED GLYCOSYLATION SEQUONS AT ASN314, ASN351, COMPND 8 ASN359, ASN376, AND ASN381 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GUANARITO VIRUS; SOURCE 3 ORGANISM_TAXID: 45219; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: HUMAN EMBRYONIC KIDNEY 293S; SOURCE 8 EXPRESSION_SYSTEM_ATCC_NUMBER: CRL-1573; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: POPINTTGNEO; SOURCE 11 OTHER_DETAILS: SYNTHETICALLY OPTIMIZED CDNA (GENEART) KEYWDS VIRAL PROTEIN, ARENAVIRUS, VENEZUELAN HEMORRHAGIC FEVER, KEYWDS 2 GLYCOPROTEIN, FUSION GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR M.PARSY,J.T.HUISKONEN,K.HARLOS,T.A.BOWDEN REVDAT 4 20-DEC-23 4C53 1 HETSYN REVDAT 3 29-JUL-20 4C53 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE ATOM REVDAT 2 20-NOV-13 4C53 1 JRNL REVDAT 1 02-OCT-13 4C53 0 JRNL AUTH M.PARSY,K.HARLOS,J.T.HUISKONEN,T.A.BOWDEN JRNL TITL CRYSTAL STRUCTURE OF VENEZUELAN HEMORRHAGIC FEVER VIRUS JRNL TITL 2 FUSION GLYCOPROTEIN REVEALS A CLASS 1 POST-FUSION JRNL TITL 3 ARCHITECTURE WITH EXTENSIVE GLYCOSYLATION. JRNL REF J.VIROL. V. 87 13070 2013 JRNL REFN ISSN 0022-538X JRNL PMID 24049182 JRNL DOI 10.1128/JVI.02298-13 REMARK 2 REMARK 2 RESOLUTION. 4.14 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.14 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 5821 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.256 REMARK 3 R VALUE (WORKING SET) : 0.255 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.450 REMARK 3 FREE R VALUE TEST SET COUNT : 259 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 5 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 4.14 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 4.63 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.59 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1630 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2913 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1563 REMARK 3 BIN R VALUE (WORKING SET) : 0.2895 REMARK 3 BIN FREE R VALUE : 0.3371 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.11 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 67 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2649 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 358 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 171.9 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 222.8 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 14.07580 REMARK 3 B22 (A**2) : 14.07580 REMARK 3 B33 (A**2) : -28.15160 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 1.869 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.795 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.908 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3091 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4222 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 971 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 94 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 643 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3091 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 489 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3491 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.38 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.80 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 25.71 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C53 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058280. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 3.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.953 REMARK 200 MONOCHROMATOR : SINGLE BOUNCE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 5894 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.140 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 26.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 4.14 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 4.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 1.00000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3MKO REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.15 M LI2SO4, 0.1 M CITRIC ACID PH REMARK 280 3.5, 18% W/V PEG 6000 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 39.37000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 19.68500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 59.05500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15990 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21540 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 290 REMARK 465 GLY A 291 REMARK 465 ASP A 292 REMARK 465 TYR A 357 REMARK 465 ILE A 358 REMARK 465 ASN A 359 REMARK 465 HIS A 360 REMARK 465 THR A 361 REMARK 465 LYS A 362 REMARK 465 SER A 363 REMARK 465 GLY A 364 REMARK 465 GLU A 365 REMARK 465 HIS A 366 REMARK 465 GLU A 404 REMARK 465 TYR A 405 REMARK 465 GLN A 406 REMARK 465 ASP A 407 REMARK 465 ARG A 408 REMARK 465 GLN A 409 REMARK 465 GLY A 410 REMARK 465 LYS A 411 REMARK 465 THR A 412 REMARK 465 PRO A 413 REMARK 465 LEU A 414 REMARK 465 THR A 415 REMARK 465 LEU A 416 REMARK 465 VAL A 417 REMARK 465 ASP A 418 REMARK 465 GLY A 419 REMARK 465 THR A 420 REMARK 465 LYS A 421 REMARK 465 HIS A 422 REMARK 465 HIS A 423 REMARK 465 HIS A 424 REMARK 465 HIS A 425 REMARK 465 HIS A 426 REMARK 465 HIS A 427 REMARK 465 THR B 290 REMARK 465 GLY B 291 REMARK 465 ASP B 292 REMARK 465 ARG B 408 REMARK 465 GLN B 409 REMARK 465 GLY B 410 REMARK 465 LYS B 411 REMARK 465 THR B 412 REMARK 465 PRO B 413 REMARK 465 LEU B 414 REMARK 465 THR B 415 REMARK 465 LEU B 416 REMARK 465 VAL B 417 REMARK 465 ASP B 418 REMARK 465 GLY B 419 REMARK 465 THR B 420 REMARK 465 LYS B 421 REMARK 465 HIS B 422 REMARK 465 HIS B 423 REMARK 465 HIS B 424 REMARK 465 HIS B 425 REMARK 465 HIS B 426 REMARK 465 HIS B 427 REMARK 465 THR C 290 REMARK 465 GLY C 291 REMARK 465 ASP C 292 REMARK 465 SER C 293 REMARK 465 GLU C 294 REMARK 465 ASN C 359 REMARK 465 HIS C 360 REMARK 465 THR C 361 REMARK 465 LYS C 362 REMARK 465 SER C 363 REMARK 465 GLY C 364 REMARK 465 GLU C 365 REMARK 465 HIS C 366 REMARK 465 SER C 367 REMARK 465 LEU C 368 REMARK 465 ASP C 407 REMARK 465 ARG C 408 REMARK 465 GLN C 409 REMARK 465 GLY C 410 REMARK 465 LYS C 411 REMARK 465 THR C 412 REMARK 465 PRO C 413 REMARK 465 LEU C 414 REMARK 465 THR C 415 REMARK 465 LEU C 416 REMARK 465 VAL C 417 REMARK 465 ASP C 418 REMARK 465 GLY C 419 REMARK 465 THR C 420 REMARK 465 LYS C 421 REMARK 465 HIS C 422 REMARK 465 HIS C 423 REMARK 465 HIS C 424 REMARK 465 HIS C 425 REMARK 465 HIS C 426 REMARK 465 HIS C 427 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 SER A 393 OG REMARK 470 ARG C 354 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 352 -113.20 19.67 REMARK 500 THR A 353 -130.84 21.20 REMARK 500 ARG A 354 -158.39 -107.70 REMARK 500 ARG A 370 129.09 -174.88 REMARK 500 CYS A 371 142.17 56.14 REMARK 500 ASN A 376 0.46 -69.94 REMARK 500 GLU B 294 -29.62 61.84 REMARK 500 TYR B 352 -30.41 14.14 REMARK 500 THR B 361 91.61 -59.84 REMARK 500 LYS B 362 42.91 -65.31 REMARK 500 GLU B 365 142.33 41.48 REMARK 500 SER B 367 -31.88 41.43 REMARK 500 LEU B 368 95.21 -7.62 REMARK 500 PRO B 369 120.94 -10.59 REMARK 500 ARG B 370 -37.27 -143.59 REMARK 500 ASN B 376 0.49 -69.26 REMARK 500 ASN B 387 23.66 -66.92 REMARK 500 LYS B 403 27.26 -78.92 REMARK 500 TYR B 405 -42.86 -20.41 REMARK 500 GLN B 406 85.64 -22.01 REMARK 500 LEU C 345 39.32 -75.13 REMARK 500 ASN C 351 -86.35 65.58 REMARK 500 ARG C 354 -153.66 -112.25 REMARK 500 PHE C 355 44.74 -87.12 REMARK 500 TYR C 357 97.46 -67.67 REMARK 500 ASN C 376 0.45 -69.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 4C53 A 292 418 UNP A1A3Z2 A1A3Z2_GTOVV 292 418 DBREF 4C53 B 292 418 UNP A1A3Z2 A1A3Z2_GTOVV 292 418 DBREF 4C53 C 292 418 UNP A1A3Z2 A1A3Z2_GTOVV 292 418 SEQADV 4C53 THR A 290 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 GLY A 291 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 GLY A 419 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 THR A 420 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 LYS A 421 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS A 422 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS A 423 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS A 424 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS A 425 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS A 426 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS A 427 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 THR B 290 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 GLY B 291 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 GLY B 419 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 THR B 420 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 LYS B 421 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS B 422 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS B 423 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS B 424 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS B 425 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS B 426 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS B 427 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 THR C 290 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 GLY C 291 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 GLY C 419 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 THR C 420 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 LYS C 421 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS C 422 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS C 423 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS C 424 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS C 425 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS C 426 UNP A1A3Z2 EXPRESSION TAG SEQADV 4C53 HIS C 427 UNP A1A3Z2 EXPRESSION TAG SEQRES 1 A 138 THR GLY ASP SER GLU PHE CYS ASP MET LEU ARG LEU PHE SEQRES 2 A 138 ASP PHE ASN LYS ASN ALA ILE GLU LYS LEU ASN ASN GLN SEQRES 3 A 138 THR LYS THR ALA VAL ASN MET LEU THR HIS SER ILE ASN SEQRES 4 A 138 SER LEU ILE SER ASP ASN LEU LEU MET ARG ASN LYS LEU SEQRES 5 A 138 LYS GLU VAL LEU LYS VAL PRO TYR CYS ASN TYR THR ARG SEQRES 6 A 138 PHE TRP TYR ILE ASN HIS THR LYS SER GLY GLU HIS SER SEQRES 7 A 138 LEU PRO ARG CYS TRP LEU VAL SER ASN GLY SER TYR LEU SEQRES 8 A 138 ASN GLU SER ASP PHE ARG ASN GLU TRP ILE LEU GLU SER SEQRES 9 A 138 ASP HIS LEU ILE ALA GLU MET LEU SER LYS GLU TYR GLN SEQRES 10 A 138 ASP ARG GLN GLY LYS THR PRO LEU THR LEU VAL ASP GLY SEQRES 11 A 138 THR LYS HIS HIS HIS HIS HIS HIS SEQRES 1 B 138 THR GLY ASP SER GLU PHE CYS ASP MET LEU ARG LEU PHE SEQRES 2 B 138 ASP PHE ASN LYS ASN ALA ILE GLU LYS LEU ASN ASN GLN SEQRES 3 B 138 THR LYS THR ALA VAL ASN MET LEU THR HIS SER ILE ASN SEQRES 4 B 138 SER LEU ILE SER ASP ASN LEU LEU MET ARG ASN LYS LEU SEQRES 5 B 138 LYS GLU VAL LEU LYS VAL PRO TYR CYS ASN TYR THR ARG SEQRES 6 B 138 PHE TRP TYR ILE ASN HIS THR LYS SER GLY GLU HIS SER SEQRES 7 B 138 LEU PRO ARG CYS TRP LEU VAL SER ASN GLY SER TYR LEU SEQRES 8 B 138 ASN GLU SER ASP PHE ARG ASN GLU TRP ILE LEU GLU SER SEQRES 9 B 138 ASP HIS LEU ILE ALA GLU MET LEU SER LYS GLU TYR GLN SEQRES 10 B 138 ASP ARG GLN GLY LYS THR PRO LEU THR LEU VAL ASP GLY SEQRES 11 B 138 THR LYS HIS HIS HIS HIS HIS HIS SEQRES 1 C 138 THR GLY ASP SER GLU PHE CYS ASP MET LEU ARG LEU PHE SEQRES 2 C 138 ASP PHE ASN LYS ASN ALA ILE GLU LYS LEU ASN ASN GLN SEQRES 3 C 138 THR LYS THR ALA VAL ASN MET LEU THR HIS SER ILE ASN SEQRES 4 C 138 SER LEU ILE SER ASP ASN LEU LEU MET ARG ASN LYS LEU SEQRES 5 C 138 LYS GLU VAL LEU LYS VAL PRO TYR CYS ASN TYR THR ARG SEQRES 6 C 138 PHE TRP TYR ILE ASN HIS THR LYS SER GLY GLU HIS SER SEQRES 7 C 138 LEU PRO ARG CYS TRP LEU VAL SER ASN GLY SER TYR LEU SEQRES 8 C 138 ASN GLU SER ASP PHE ARG ASN GLU TRP ILE LEU GLU SER SEQRES 9 C 138 ASP HIS LEU ILE ALA GLU MET LEU SER LYS GLU TYR GLN SEQRES 10 C 138 ASP ARG GLN GLY LYS THR PRO LEU THR LEU VAL ASP GLY SEQRES 11 C 138 THR LYS HIS HIS HIS HIS HIS HIS MODRES 4C53 ASN A 314 ASN GLYCOSYLATION SITE MODRES 4C53 ASN A 376 ASN GLYCOSYLATION SITE MODRES 4C53 ASN A 381 ASN GLYCOSYLATION SITE MODRES 4C53 ASN B 314 ASN GLYCOSYLATION SITE MODRES 4C53 ASN B 351 ASN GLYCOSYLATION SITE MODRES 4C53 ASN B 381 ASN GLYCOSYLATION SITE MODRES 4C53 ASN C 314 ASN GLYCOSYLATION SITE MODRES 4C53 ASN C 381 ASN GLYCOSYLATION SITE HET NAG D 1 14 HET NAG D 2 14 HET BMA D 3 11 HET NAG E 1 14 HET NAG E 2 14 HET NAG F 1 14 HET NAG F 2 14 HET BMA F 3 11 HET MAN F 4 11 HET MAN F 5 11 HET MAN F 6 11 HET MAN F 7 11 HET NAG G 1 14 HET NAG G 2 14 HET BMA G 3 11 HET MAN G 4 11 HET MAN G 5 11 HET MAN G 6 11 HET MAN G 7 11 HET NAG H 1 14 HET NAG H 2 14 HET BMA H 3 11 HET MAN H 4 11 HET MAN H 5 11 HET MAN H 6 11 HET MAN H 7 11 HET NAG A1407 14 HET NAG A1408 14 HET NAG B1417 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 4 NAG 13(C8 H15 N O6) FORMUL 4 BMA 4(C6 H12 O6) FORMUL 6 MAN 12(C6 H12 O6) HELIX 1 1 SER A 293 LYS A 340 1 48 HELIX 2 2 LEU A 341 LEU A 345 5 5 HELIX 3 3 ASN A 387 LYS A 403 1 17 HELIX 4 4 GLU B 294 LEU B 341 1 48 HELIX 5 5 LYS B 342 LEU B 345 5 4 HELIX 6 6 TYR B 352 THR B 361 1 10 HELIX 7 7 ASN B 387 LYS B 403 1 17 HELIX 8 8 PHE C 295 LEU C 341 1 47 HELIX 9 9 LYS C 342 LEU C 345 5 4 HELIX 10 10 ASN C 387 LYS C 403 1 17 SSBOND 1 CYS A 350 CYS A 371 1555 1555 2.69 SSBOND 2 CYS B 350 CYS B 371 1555 1555 2.73 SSBOND 3 CYS C 350 CYS C 371 1555 1555 2.78 LINK ND2 ASN A 314 C1 NAG A1407 1555 1555 1.43 LINK ND2 ASN A 376 C1 NAG A1408 1555 1555 1.43 LINK ND2 ASN A 381 C1 NAG D 1 1555 1555 1.43 LINK ND2 ASN B 314 C1 NAG E 1 1555 1555 1.43 LINK ND2 ASN B 351 C1 NAG F 1 1555 1555 1.43 LINK ND2 ASN B 381 C1 NAG B1417 1555 1555 1.43 LINK ND2 ASN C 314 C1 NAG H 1 1555 1555 1.43 LINK ND2 ASN C 381 C1 NAG G 1 1555 1555 1.43 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG D 2 C1 BMA D 3 1555 1555 1.45 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.43 LINK O4 NAG F 1 C1 NAG F 2 1555 1555 1.44 LINK O4 NAG F 2 C1 BMA F 3 1555 1555 1.43 LINK O6 BMA F 3 C1 MAN F 4 1555 1555 1.41 LINK O3 BMA F 3 C1 MAN F 7 1555 1555 1.42 LINK O3 MAN F 4 C1 MAN F 5 1555 1555 1.43 LINK O6 MAN F 4 C1 MAN F 6 1555 1555 1.41 LINK O4 NAG G 1 C1 NAG G 2 1555 1555 1.44 LINK O4 NAG G 2 C1 BMA G 3 1555 1555 1.42 LINK O6 BMA G 3 C1 MAN G 4 1555 1555 1.40 LINK O3 BMA G 3 C1 MAN G 7 1555 1555 1.42 LINK O3 MAN G 4 C1 MAN G 5 1555 1555 1.43 LINK O6 MAN G 4 C1 MAN G 6 1555 1555 1.41 LINK O4 NAG H 1 C1 NAG H 2 1555 1555 1.41 LINK O4 NAG H 2 C1 BMA H 3 1555 1555 1.42 LINK O6 BMA H 3 C1 MAN H 4 1555 1555 1.41 LINK O3 BMA H 3 C1 MAN H 7 1555 1555 1.43 LINK O3 MAN H 4 C1 MAN H 5 1555 1555 1.45 LINK O6 MAN H 4 C1 MAN H 6 1555 1555 1.41 CRYST1 98.500 98.500 78.740 90.00 90.00 90.00 P 41 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010152 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010152 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012700 0.00000